Use of Lotion of Rhinacanthus nasutus,a medicinal plant, in skin itch (Scabies)

A Preclinical and Clinical Study to evaluate the efficacy of lotion composed of Rhinacanthus nasutus Linn. Kurz in patients suffering from Pama kustha w.s.r. to Scabies - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102794

Enrollment

Registered

2026-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L54- Erythema in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. All diagnosed cases of Pama kustha/scabies, irrespective of caste, religion, sex or socio-economic status. 2. Age - 5 years to 60 years

Exclusion criteria

Exclusion criteria: 1. Patients suffering from any other systemic disorders such as skin tuberculosis, leprosy etc. 2. Patients suffering from other types of kustha roga. 3.Scabies/Pama kustha with immunodeficiency disorders.

Design outcomes

Primary

Measure	Time frame
1.To determine the efficacy of the extracts of whole plant of Rhinacanthus nasutus Linn. Kurz as anti-scabies agent. Timepoint: 1.Literature review, collection of samples, pharmacognosy-2 months 2.Phytochemical study-2 months 3.Preparation of the test drug, experimental Study-3 months 4. Clinical study-8 months 5.Statistical analysis and compilation-3 months	—

Secondary

Measure	Time frame
1.Effectiveness in reducing the secondary symptoms of scabies like- itching and skin inflammation. 2.Providing evidences supporting its use as a safe, accessible and cost-effective treatment for scabies. 3.Laying out the groundwork for further pharmacological development or clinical trials about Rhinacanthus nasutus Linn. Kurz for future researchers. Timepoint: 1.Literature review, collection of samples, pharmacognosy-2 months 2.Phytochemical study-2 months 3.Preparation of the test drug, experimental Study-3 months 4. Clinical study-8 months 5.Statistical analysis and compilation-3 months	—

Measure

Time frame

1.Effectiveness in reducing the secondary symptoms of scabies like- itching and skin inflammation. 2.Providing evidences supporting its use as a safe, accessible and cost-effective treatment for scabies. 3.Laying out the groundwork for further pharmacological development or clinical trials about Rhinacanthus nasutus Linn. Kurz for future researchers. Timepoint: 1.Literature review, collection of samples, pharmacognosy-2 months 2.Phytochemical study-2 months 3.Preparation of the test drug, experimental Study-3 months 4. Clinical study-8 months 5.Statistical analysis and compilation-3 months

—

Countries

India

Contacts

Public ContactRajendra Jana

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital

dr.sureshkjaiswara@gmail.com9681098261

Outcome results